Bioactive collagen peptides are hydrolysed collagen peptides sold under a trademark that names a specific peptide profile and the trials run on it. Those trials belong to the profile, not to collagen generally. TARE’s Under Load carries no such licence: its certificate — ViaCore Nutrition, the maker’s own laboratory, 22 December 2025 — names collagen peptides and nothing more.
Hydrolysed collagen is collagen protein cut into short chains. Every collagen peptide powder on the shelf is that, including this one. What separates them on a label is usually not the substance — it is whether the substance has been given a name of its own.
Which makes this a paperwork question rather than a chemistry question, and paperwork questions are the ones this brand is for.
What is a bioactive collagen peptide?
It is hydrolysed collagen that a supplier has cut to a target peptide profile, given a trademark, and run trials on. Bioactive is not a regulated word and it is not a grade. It asserts that the fragments in that particular powder do something in the body, and it is the trademark, not the adjective, that carries whatever evidence exists.
So a tub saying collagen peptides and a tub saying bioactive collagen peptides are describing the same class of material. The second one is telling you something extra about its supplier. That is worth having, and it is worth knowing exactly what it is.
What does a peptide-profile trademark actually buy?
A named producer, a defined hydrolysis process, a peptide profile held constant from one production run to the next, and — in the cases that matter — a set of trials run on that profile and no other. Those trials are the substantive content of the claim. They are evidence about one supplier’s material entering a finished product.
Two things follow, and the second is the one nobody says. First, this is a real signal, because a buyer cannot cut a powder open and check where the chains were broken; a licence is one of the few upstream facts a label can carry that a reader could not establish for himself. Second, a trial run on a trademarked profile is evidence for that profile, not for collagen. A brand that licenses the material inherits the paperwork. A brand that does not cannot borrow it, and should not write as though it had.
What does a molecular weight or peptide-profile figure tell a buyer?
On its own, very little. An average molecular weight in daltons describes how small the fragments are, not what they do. There is no published threshold above or below which collagen peptides start or stop working, and the figure is almost never printed beside the method that produced it or the specification it was measured against.
A figure with no method and no specification behind it is a marketing number. The same figure on a certificate — instrument named, specification stated, sample identified — is a result. What a certificate of analysis reports, and what it cannot is a whole article of its own, and the distinction it turns on is the one that decides this comparison. A specification is a target the maker set. A result is what an instrument returned. Only one of them is evidence.
What can you actually verify from a label and a certificate?
Four things, and a trademark is not one of them: the ingredient line, the Supplement Facts panel, whether a certificate exists at all, and what that certificate covers. Everything else on the front of a tub is a claim about someone you cannot phone. Here is the order to read them in.
- Read the ingredient line first. One ingredient is a fact you can check in two seconds. A blend is not, and a blend that hides its ratios is a proprietary blend — the one label construction that makes verification impossible by design.
- Match the trademark to a document. If a tub names a branded peptide, the licence is provable and the trials on that profile are findable. If it names one and shows nothing, the name is doing work the paperwork should be doing.
- Read whose sample the certificate covers — the finished powder you would receive, or raw material bought upstream by somebody else. Those are different documents with different weights, and the difference is usually printed in the customer field.
- Check which properties were run, and which were not. A result column with nothing in it is often the most informative line on a certificate.
- Check the dose against the trial. A licensed profile studied at one amount tells you nothing about a tub that delivers a fraction of it.
That procedure is written out at length in the sixty-second label procedure. It works on any tub in the category, and it works on this one, which is the only reason it is worth publishing.
What does TARE’s own label say?
Under Load declares bovine collagen peptides, Type I and III — one ingredient, unflavoured, net 350 g — and names no branded ingredient, because our certificate does not name one. We are not going to assert a licence we cannot show a document for, and we are not going to imply one by leaving the question decorative.
The certificate says the same thing in fewer words. Its ingredients line reads collagen peptides and stops — lot 121125450, a 10 g serving, analysed 22 December 2025. ViaCore Nutrition of El Reno, Oklahoma — the laboratory belonging to the company that makes the powder, not an outside one — measured protein at 9.8 g against a 9 g specification by ISO 14891:2002, and lead at 0.07 mcg against a Proposition 65 limit of 0.5 mcg, with mercury, arsenic and cadmium below the detectable limit. Those are real results on the lot our own tub was filled from, and they came from the softest chain of custody of the three documents this brand holds, which is why the laboratory is named in the same breath as its figures rather than in a footnote. The whole certificate is transcribed row by row on Testing & Certification.
The front panel also carries the words grass-fed, and the manufacturer confirmed the source country in writing as Brazil. It is worth being exact about how much that buys, because this is the same trap in a different word: grass-fed hide is the category standard rather than a distinction. The claim is true and it is not an argument. The back of the tub is where the argument is.
What is not on the panel is the protocol. The Supplement Facts panel is locked and states 10 g — two 5 g scoops — and 35 servings, and that is the declared serving, full stop. The amount the tendon literature actually used is 15 g, which appears on this site as a direction and never as a serving: three scoops, 30 to 60 minutes before training, on training days, with 50 to 100 mg of vitamin C that is not in the tub. The arithmetic that follows from it, including what it costs this 350 g tub, is its own article, because the answer subtracts.
What the research does and does not show
No study demonstrates that one supplier’s collagen peptides outperform another’s. That is not a gap somebody forgot to fill. Trials are run on the material whose owner paid for them, so a trial on a trademarked profile is a result about that profile and not a comparison — there is nothing on the other side of it. Absence of a head-to-head is the normal condition of this category, and reading it as a verdict in either direction is the error.
The evidence under the whole category is thinner than the marketing implies, and the honest version is short. The trial this site’s protocol comes from used gelatin, not a branded peptide — Shaw and colleagues, Am J Clin Nutr 2017, 5 g against 15 g of gelatin with vitamin C, one hour before loading, where 15 g roughly doubled serum PINP. n = 8 healthy males, and the endpoint was a blood marker, not a tendon. Saying so costs this page something. Not saying it would cost more.
What came afterwards does not rescue it. A 2026 systematic review in JFMK reports tendon cross-sectional area and stiffness rising at 15 to 30 g a day with loading — the loading is not decoration in that sentence, it is the condition — and 30 g produced nothing beyond 15 g. The trials disagree, and the largest one says no: Balshaw and colleagues, MSSE 2023 — n = 39, 15 g a day, 15 weeks of training, the tendon measured by MRI — found no difference from placebo on any tendon measure, and it was not funded by industry. That same 2026 JFMK review grades the evidence strong — GRADE A — against an effect on muscle strength, and the 2024 Sports Medicine meta-analysis that did find an effect measured it at SMD 0.19 — trivially small, and low-certainty by its authors’ own rating. No randomised trial shows a reduced injury rate. Aussieker and van Loon reported in 2023 that 30 g after exercise produced no increase in muscle connective protein synthesis, which is why collagen is not a muscle-building protein and TARE does not sell it as one. And a 2025 review in Am J Medicine of 23 randomised trials, n = 1,474, found that the independently funded ones showed no effect on skin, so TARE makes no skin claim at all.
Set that against the trademark question and the shape of the answer is clear enough. A licensed profile may well have more evidence behind it than the generic material does. What it does not have is evidence that the licence is what did it, and a buyer paying for the name is paying for a document he can usually neither read nor find.
The one comparison that is genuinely decidable is what you can check. The ingredient line, the declared amount, the timing, and whether anyone will show you the certificate and let you read the fields that embarrass them. Everything else here is a licence you either hold or do not hold, and we do not.
More in this cluster: how much collagen a tendon protocol actually uses, what a certificate of analysis actually reports, the sixty-second label procedure, what a proprietary blend hides, the same question, asked about creatine, and whether collagen and creatine can be taken together.